tiprankstipranks
Sorrento Therapeutics (SRNE)
OTHER OTC:SRNE

Sorrento Therapeutics (SRNE) Stock Investors

5,280 Followers
Based on 739,227 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold SRNE
On average, investors allocate 2.05% of their portfolios to SRNE
The average holding size of this company in investors' portfolios.

Investor Sentiment

Negative
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 739,227 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding SRNE

0.2%
Last 7
Days
2.1%
Last 30
Days
Percentages indicate the change in the number of portfolios holding SRNE, out of 739,227 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

SRNE Investor Activity

Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Increased
0.00%
$0.12
Increased
0.16%
$0.03
Based on the activity of 13,978 investors who made their portfolios public
The table shows changes in SRNE in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

SRNE Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
DraftKings
5.77%
-0.13%
+1.22%
32.34B
Consumer Cyclical
Block
4.19%
-0.42%
-1.06%
40.17B
Technology
Plug Power
4.99%
-1.08%
-2.76%
2.15B
Industrials
ChargePoint Holdings
4.02%
-0.73%
-2.29%
765.55M
Consumer Cyclical
GE Aerospace
5.36%
-0.31%
-0.88%
177.24B
Industrials
Blink Charging Co
5.18%
-1.13%
-3.83%
309.24M
Industrials
Riot Platforms
4.96%
-0.82%
-0.37%
2.81B
Financial
AMC Entertainment
5.55%
-0.10%
+7.78%
1.45B
Communication Services
Marathon Digital Holdings
5.47%
-0.34%
-1.27%
5.26B
Financial
Boeing
5.82%
-0.52%
-2.30%
116.79B
Industrials
Based on the activity of 739,227 active portfolios
Open your Smart Portfolio

SRNE Investor Analysis

SRNE investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
10.5%
of SRNE holders
are under 35
Average Segment Performance
Average P/E Ratio20.54
Beta6.48
Dividend Yield6.25%
SRNE investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
52.4%
of SRNE holders
are between 35–55
Average Segment Performance
Average P/E Ratio19.66
Beta11.65
Dividend Yield6.39%
SRNE investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
37.1%
of SRNE holders
are over 55
Average Segment Performance
Average P/E Ratio19.45
Beta4.12
Dividend Yield7.17%
Overview of age group and performance of SRNE stock investors
See who invests in SRNE according to age group and performance.

FAQ

How many retail Investors hold SRNE?
<0.1% of TipRanks' retail investors hold SRNE in their portfolios.
    What is SRNE Investor Sentiment?
    SRNE’s Investor Sentiment is Negative.
      What percentage of retail investors changed their holding of SRNE in the last 7 days?
      ▲ 0.2% of TipRanks' retail investors changed their holding of SRNE in the last 7 days.
        What percentage of retail investors changed their holding of SRNE in the last 30 days?
        ▼ 2.1% of TipRanks' retail investors changed their holding of SRNE in the last 30 days.
          What is the average age of retail investors who hold SRNE?
          The average age of SRNE Holders is between 35–55.
            What other stocks have SRNE investors also bought?
            SRNE Investors also bought DKNG, SQ, PLUG, CHPT, GE, BLNK, RIOT, AMC, MARA, BA.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ACADACADIA Pharmaceuticals
              ALGNAlign Tech
              BDXBecton Dickinson
              BIIBBiogen
              BSXBoston Scientific
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis